Le Lézard
Classified in: Covid-19 virus
Subjects: MAV, CPN, CFG

Media Advisory - Technical Briefing for Media: Supporting a Safe Election during the Pandemic


OTTAWA, ON, Dec. 10, 2020 /CNW/ - Government of Canada officials will hold a technical briefing to provide an overview of An Act to amend the Canada Elections Act (COVID-19 response).

Date:
Thursday, December 10, 2020

Time: 
12:00 p.m. EST

Location:

The technical briefing will be held virtually via teleconference.

Toll-free (Canada/US) dial-in number: 1-888-265-0903

Local dial-in number: 613-960-7527

Passcode: 5675022#

Stay Connected

https://www.canada.ca/en/democratic-institutions.html

Twitter: https://twitter.com/CdnDemocracy

SOURCE Minister for Democratic Institutions


These press releases may also interest you

at 08:25
Nova Leap Health Corp. Announces Execution of Definitive Agreement
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the...

at 08:20
Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...

at 08:09
Adyton Resources Announces Filing of Financial Statements and MD&A for the three and twelve months ended December 31, 2023
Adyton Resources Corporation announces that it has filed its financial statements for the three and twelve months ended December 31, 2023 and accompanying Management Discussion and Analysis on its SEDAR profile at www.sedar.com. ...

at 08:05
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:00
Global Men's Health and Wellness Market Analysis Report 2024: Market to Surpass $2.5 Trillion by 2029 from $1.27 Trillion in 2023, Driven by Celebrity Endorsements and Influencer Marketing - ResearchAndMarkets.com
The "Global Men's Health and Wellness Market: Analysis By Type, By Distribution Channel, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. In 2023, the...

at 08:00
Citius Pharmaceuticals Announces $15 Million Registered Direct Offering
Citius Pharmaceuticals Inc. ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive...

More news about Covid-19 virus...


News published on and distributed by: